Clinical Trial

Neuropsychomotor Development From Ages 6 to 18 in Children With Early Surgically Treated Congenital Heart Disease

Study acronym: NEUROTECH
Completed
View on ClinicalTrials.gov →
Summary
This study will invite parents of children who underwent surgical treatment for congenital heart disease to complete a validated proxy-report questionnaire assessing executive and psychosocial functioning. The instrument used will be the French version of the Strengths and Difficulties Questionnaire (SDQ), validated for children aged 6-17 years, which evaluates cognitive, executive, and mental health domains and provides both global and subdomain scores. After a telephone explanation, the questionnaire will be sent to parents of eligible children aged 6-18 years and returned by post once completed. This methodology is modeled on follow-up networks for vulnerable newborns, where parent-completed questionnaires are completed at home and mailed back.
Trial Details
NCT Number NCT07437261
Lead Sponsor University Hospital, Toulouse
Conditions Congenital Cardiomyopathy
Enrollment 155 participants
Start Date 2025-02-08
Primary Completion 2026-02-08 (estimated)
Study Completion 2026-02-08 (estimated)
Updated on ClinicalTrials.gov 2026-02-27